LGMC Conducting Research Study on Lung Cancer

2/27/2015

Cancer Center of Acadiana (CCA) at Lafayette General Medical Center (LGMC) is seeking men and women ages 18 and older who are current or former smokers diagnosed with Non-Squamous Non-Small Cell Lung Cancer to participate in a clinical research study.

This research will study the effectiveness of an investigational drug in combination with standard chemotherapy treatments in subjects receiving their first Chemotherapy for Metastatic or Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC).

The Lung Mass Clinic at CCA is the state’s only dedicated lung diagnostic testing center. It has a group of physicians dedicated to handling potential lung cancer cases, offering patients access to the largest range of diagnostic testing available under one roof in Louisiana.

CCA participates in clinical trials and research studies to possibly improve patient care in the future. Clinical trials can offer possible access to newer investigational drugs that might not otherwise be available. Trials also help expand knowledge about the best ways to treat cancer in the future.

Physicians, nurses and other team members at CCA will thoroughly instruct a patient on potential risks and benefits of participating in a clinical trial. The staff will then closely monitor and assess the progress of the trial and continue this through follow-up study-related care.

When patients participate in a clinical trial, they are not only advancing medical technology, they are providing a valuable benefit to future generations. The goal of clinical trials at Lafayette General Medical Center is to support the patient-centered approach to research study-related care.

For more information on this and other clinical trials available at Lafayette General Medical Center, call (337) 289-8658 or visit our clinical trials on cancer page

Back to News Listing